| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Académie des technologies [Automatic translation follows] For reasoned progress, chosen shared Founded in 2000, the Academy of Technologies brings together 370 academics, including five Nobel Prize winners, all experts in their respective fields, and from very diverse backgrounds: the world of industrial and academic research, economists, sociologists, architects. , doctors, etc. It analyzes the opportunities and risks linked to new technologies, and is committed to improving the attractiveness of technological professions, particularly among young people and women. The Academy issues proposals and recommendations to public authorities, socio-economic stakeholders and citizens for better exploitation of technologies for the benefit of people, in accordance with … Type: | 64 | 12 | 69 | 85 |
 | SISTAFUND We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams. SISTAFUND is a pan-European VC fund backing female founders and gender-balanced teams, building companies that challenge the status quo. With a target of €100 million, SISTAFUND will be deployed from pre-seed to Series A, mainly in France and Europe, with some investments in the U.S. SISTAFUND’s ambition is twofold: Drive the performance of backed companies, since start-ups founded or co-founded by women are 2.5 times more profitable investments … Type: | 48 | 11 | 45 | 7 |
 |  Nuage Therapeutics We develop new selective and potent drugs for intrinsically disordered targets. Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA. Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs. Type: | 4 | 1 | 2 | 21 |
 |  Womed This is a women's world Womed is pioneering innovative, safe and effective treatments to free women from challenging uterine pathologies: infertility, uterine bleeding, endometriosis. Type: | 10 | 1 | 1 | 12 |
 | Umiami The next generation of plant-based meat. Tasty, Tender, and Sustainable whole-cuts. Umiami is a French foodtech that was founded in 2020 with the mission to reduce worldwide meat consumption and its impact on health, animals, and the environment. We are pioneers in the development of a patent-pending process for texturizing plant proteins called "umisation". With our umisation technology, we can recreate the meat and fish fillet experience without compromising on taste and texture. After opening our first pilot plant innovation center last year, Umiami will inaugurate its first large-scale production plant in October 2023. The 14,000m2 site is located in … Tags: FrenchTech2030 Type: | 34 | 19 | 20 | 105 |
 | Home Biosciences A new breed of biotech company A new breed of biotech company aiming to unlock scientific breakthrough by leveraging an asset-centric operating model Type: | 5 | 4 | 2 | 9 |
 | Form the Future CIC We help young people find their route through education into employment, and provide employers access to future talent We connect young people to a world of career possibilities, inspire them to dream big and empower them to fulfil their potential. We want to equip young people with the experience and skills they will need to succeed in their career of choice, and enable businesses to recruit skilled workers locally. We bridge the gap between these two worlds and help them work together and achieve more. We deliver the skills service for the Greater Cambridge Partnership, linking schools and businesses to … Type: | 10 | 0 | 8 | 37 |
 | Tigem Telethon Institute of Genetics and Medicine TIGEM is a multidisciplinary research Institute devoted to the study of the mechanisms underlying rare genetic diseases and to the development of new therapies. The institute is one of the most important centers for fundamental life science research in Italy (https://www.tigem.it/). It is particularly renowned for its research on diseases such as lysosomal disorders, membrane trafficking defects, disorders of liver metabolism, and eye diseases. The unique funding environment of TIGEM forges important critical mass and facilitates opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake. TIGEM is a … Type: | 1 | 1 | 1 | 299 |
 | Novozymes Novozymes has combined with Chr. Hansen to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet. Novozymes was formed in 2000 when Novo Nordisk split into three companies: Novo Nordisk A/S, Novozymes A/S and Novo A/S. Novozymes was the world leader in biological solutions with a commitment to Rethink Tomorrow. It served 130 markets with enzymatic, microbial and advanced protein solutions. The company’s solutions enabled higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel … Type: | 12 | 2 | 11 | 4,489 |
 | Bien Commun Advisory [Automatic translation follows] The conviction that, in the “common good”, the greatest good is first and foremost what is common to us. Bien Commun Advisory is a consulting firm in communications strategy, economic information, public affairs and media relations. Founded by Antoine Boulay in 2019, it now has around fifteen employees and operates for large companies, SMEs, start-ups, federations and players in the associative world. Type: | 34 | 1 | 29 | 14 |
 | Noema Pharma Developing therapies to restore functioning in patients with orphan conditions of the brain and nervous system. Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using our novel therapies. CNS | 1 | 1 | 0 | 32 |
 | ImmuONE Specialised translational approaches and in vitro testing services ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models. We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs. … Type: | 4 | 0 | 2 | 17 |
 | AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: | 2 | 0 | 1 | 11 |
 | EnginZyme Developing technologies to meet the sustainability goals of the future Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the … Type: | 2 | 0 | 2 | 59 |
 | Mauna Kea Technologies The real-time in vivo cellular imaging platform that revolutionizes the way physicians diagnose and treat patients. Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative … Type: | 3 | 1 | 2 | 121 |
 | Le Monde [Automatic translation follows] The leading news, everywhere, all the time, from the editorial staff of Le Monde. LeMonde.fr has been present on the Internet since December 19, 1995, 51 years to the day after the creation of the paper newspaper. The site and its mobile applications are among the most consulted in France to follow news in real time (international, economy, politics, society, etc.) Leading news website in French. Journalism, Media, Online Press, Written Press, Internet, Video, and Ethics Type: | 276 | 197 | 76 | 2,722 |
 | La French Care [Automatic translation follows] The movement of health actors Our mission ? Federate the health ecosystem. French Care is the movement of health actors, it is supported by Bpifrance and the Acteurs de la French Care association, which brings together private and public actors in the health sector in France. French Care serves the development of ecosystems and excellence in the service of the patient. The mission of La French Care: to promote and develop excellence in health in France. Type: | 18 | 10 | 8 | 6 |
 | La Course des Lumières [Automatic translation follows] Together, let's light up the night against illness and for all sick people! Created in 2010, the Race of Lights is a national awareness event around the fight against disease. Since its creation, more than a million euros have been collected for the benefit of health organizations (foundations, hospitals, patient associations, etc.). Accessible to all, the event brings together more than 15,000 participants and 200 companies each year. Each participant, runner or walker, symbolically carries a luminous object to “light the night against illness and for all sick people”. solidarity, sport, running, walking, and team-building Type: | 5 | 5 | 1 | 1 |
 | ELICIT PLANT The only efficient Bio-Intrant to fight Water Stress ELICIT PLANT is an AGtech company and a pioneer in the stimulation of field-grown plants through the use of phytosterols. By reducing plant water stress, our patented technology increases yield in situation of lack of water. Elicit Plant develops and provides new effective prevention products against the stress suffered by plants grown by the intake of exogenous phytosterols in the field. Elicit Plant offers a novel solution for reducing water consumption for the cultivation of targeted plants and helps to fight against water stress. Elicit Plants develops a methodology to collect soil, … Tags: FrenchTech2030 Type: | 18 | 10 | 11 | 76 |
 | Neoplants The first generation of plants bioengineered to fight air pollution. www.neoplants.com The first generation of bioengineered plants to fight air pollution. | 15 | 10 | 8 | 37 |
 | Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: | 9 | 8 | 1 | 61 |
 | Merieux Equity Partners Invested Investors Merieux Equity Partners is a multistage investment manager specialized in the healthcare & nutrition sectors via two dedicated platforms: Venture and Growth/Buyout. As an independent General Partner - registered under the French Financial Markets Authority AMF ("Autorité des Marchés Financiers") - Merieux Equity Partners currently manages 5 main funds, representing more than €1 billion of Commitments, and has supported over 45 companies in Europe and North America since its creation - in Venture Capital and Growth/Buyout. Our passion is to work alongside entrepreneurs and companies with an ambitious growth plan, offering them privileged access to our sector-expertise and … Type: | 9 | 7 | 5 | 38 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 31 | 12 | 22 | 210 |
 | Cure51 From Cancer Survivors to new drugs The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer. Type: | 2 | 1 | 0 | 15 |
 | MaaT Pharma The leading microbiome company in oncology MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process … Type: | 25 | 8 | 21 | 77 |
 | Sensorion Our mission: find solutions for hearing disorders Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs … Type: | 12 | 6 | 6 | 69 |
 | Italian Tech Alliance [Automatic translation follows] Formerly VC Hub Italia, it is the association of Venture Capital, investors in innovation, startups and innovative SMEs Italian Tech Alliance is the reference association for: - venture capital funds; - investors in innovation; - innovative startups and SMEs. The objective of the association is to promote the development of the technology and innovation ecosystem in Italy, working closely with institutions. The contents of the Italian Tech Alliance disseminate news, opportunities and interesting reports for private and public stakeholders who work for the economic and social growth of the country. The following currently sit on the Board … Type: | 7 | 3 | 3 | 15 |
 | HarperCollins Publishers Publishing great authors since 1817. HarperCollins Publishers is the second-largest consumer book publisher in the world. Headquartered in New York, HarperCollins has publishing operations in 17 countries. With two hundred years of history and more than 120 branded imprints around the world, HarperCollins publishes approximately 10,000 new books every year in 16 languages, and has a print and digital catalog of more than 200,000 titles. Writing across dozens of genres, HarperCollins authors include winners of the Nobel Prize, the Pulitzer Prize, the National Book Award, the Newbery and Caldecott Medals, and the Man Booker Prize. HarperCollins is a subsidiary of … Type: | 15 | 4 | 11 | 4,129 |
 | The Wall Street Journal Winner of 37 Pulitzer Prizes for outstanding journalism, The Wall Street Journal includes coverage of U.S. and world news, politics, arts, culture, lifestyle, sports, health and more. It's a critical resource of curated content in print, online and mobile apps, complete with breaking news streams, interactive features, video, online columns and blogs. Since 1889, readers have trusted the Journal for accurate, objective information to fuel their decisions as well as enlighten, educate and inspire them. On LinkedIn, we will share articles to help you navigate your career, including stories from our business, management, leisure and technology sections. Subscribe: http://on.wsj.com/1n1uvCH Job … Type: | 93 | 42 | 58 | 11,023 |
 | NatureWorks A naturally advanced biomaterials company using plants to turn greenhouse gases into IngeoTM️ PLA biopolymers. NatureWorks is an advanced materials company offering a broad portfolio of renewably-sourced polymers and chemicals to the packaging, polymers, fibers, and chemicals markets. With performance and economics that compete with oil-based plastics and fibers, naturally advanced IngeoTM polymers are valued for their unique functional properties and used in products from coffee capsules and electronics to diapers and wipes. Creating performance through chemistry, VercetTM lactide-based solutions help innovators realize significant, measurable performance and cost advantages in products such as C.A.S.E., toners, and surfactants. NatureWorks is jointly … Type: | 10 | 1 | 2 | 210 |
 | Cancer Campus [Automatic translation follows] Cancer Campus is a research and innovation park developing in Villejuif (Val-de-Marne) Cancer Campus is a research and innovation park developing in Villejuif (Val-de-Marne), around Gustave Roussy, the first cancer center in Europe. Its objective is to bring together all the talents (health professionals, researchers, students, businesses) and citizens concerned by the disease to become an international reference site in innovation in health and oncology. In this context, we are developing 3 programs dedicated to promoting entrepreneurship in oncology: - the Oncoentrepreneur program: tailor-made training and support set up for start-up projects in biotech, medtech and e-health. … Type: | 5 | 1 | 3 | 3 |
 | Marks & Clerk Leading global network of intellectual property specialists We’re true specialists – focusing on IP and IP alone. With patent attorneys, trade mark attorneys, commercial lawyers and IP litigators, we can provide every type of intellectual property service you need. Our expertise is globally acknowledged - in our top tier status, the awards we’ve won and in the cutting-edge work we do, which helps shape future law. Intellectual property, Litigation, Prosecution, Patents, Trade Marks, and Law | 3 | 1 | 1 | 587 |
 | GENFIT Dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs. GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from early-stages to late development and pre-commercialization stages, is illustrated through the successful 52-week readout of its Phase 3 trial (ELATIVE®) evaluating elafibranor in Primary Biliary Cholangitis (PBC). Today, … Type: | 7 | 3 | 5 | 172 |
 | Varenne Capital Partners Varenne Capital Partners is a Paris-based, process-driven, global investment manager whose purpose is to deliver superior long-term returns with the minimum necessary risk-taking. We strive to achieve this goal by employing proprietary research and combining complementary investment frameworks in a single strategy: Long Equity, Short Equity, Merger Arbitrage and Tail Risk Hedging. Our ‘brokers are not welcome’ policy means that we rely exclusively on our own internal research and base our analysis on facts and figures. All of our investment frameworks stem from years of research and development and as a result comprise original methodologies, formalized processes, dedicated teams of … Type: | 5 | 2 | 1 | 38 |
 | GFBiochemicals GFBiochemicals is on a mission to create a more sustainable future and transform the chemicals industry GFBiochemicals is a biochemical company that specializes in the research, development, production and business development of bio-based and renewable chemicals. We provide high-quality, bio-based chemicals to businesses across the world. Our focus is green chemistry – a sustainable alternative to traditional oil-based chemistry. Our technology is proprietary and has been developed in-house over many years. GFBiochemicals is headquartered in Paris, France and has subsidiaries in Geleen, the Netherlands and Minneapolis, USA. GFBiochemicals acquired Segetis, in 2016, as part of our growth strategy to integrate … Type: | 5 | 2 | 3 | 33 |
 | Quest for health [Automatic translation follows] Healthcare accelerator in the heart of Europe. For biotech, medtech and digital health startups. Quest for health is the Grand Est incubator dedicated to health start-ups at European level. Born from the initiative of the Quest for change network of incubators (based in Reims, Strasbourg, Metz, Charleville-Mézières, Epinal and Mulhouse), the incubator supports more than sixty biotech, medtech and e-health start-ups. Quest for health is positioned as the leading player at the national level in this field. Among the start-ups supported, 21 are winners of the national i-Lab competition (including four grand prizes), five of the i-Nov … Type: | 40 | 11 | 38 | 6 |
 | Groupe Stratos Groupe STRATOS is an entrepreneurs community providing companies with custom-made solutions. Groupe STRATOS is an entrepreneurs community providing companies with custom-made solutions. Our community is composed of entrepreneurs with expertise on a specific topic and each single member is/was an entrepreneur. Groupe STRATOS was founded in 2020 with the merger of 2 other companies created 10 & 20 years ago. About our advisory activiy : - Fund raisings through our network of +1 000 investors (France & International) - Mergers & Acquisitions - Financial audits (M&A, valuation of companies, due diligence...) - Financial analysis - Strategy & business development - … Type: | 54 | 2 | 54 | 8 |
 | France Deeptech [Automatic translation follows] When science undertakes The community that brings together deeptech players for an entrepreneurial, collective and scientific response to our contemporary challenges Type: | 44 | 11 | 39 | 6 |
 | IMS (Institut du Médicament de Strasbourg) [Automatic translation follows] Interdisciplinary Thematic Institute of the University of Strasbourg The Strasbourg Medicine Institute responds to the challenges of the medicines sector: producing cutting-edge research up to the pre-clinical stage, promoting technological innovation through the creation of start-ups and training the new generation of researchers in management of drug innovation. Type: | 13 | 2 | 7 | 6 |
 | Biotalys Reinventing food protection We are a rapidly growing and transformative food and crop protection company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on our ground-breaking technology platform, Biotalys is developing a broad pipeline of effective and safe products with novel modes of action, addressing key crop pests and diseases across the whole value chain, from soil to plate. Biotalys’ unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. We are … Type: | 6 | 3 | 5 | 69 |
 | RefleXion Medical SCINTIX biology-guided radiotherapy is now FDA cleared. SCINTIX biology-guided radiotherapy now FDA cleared. SCINTIX® therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease. cancer care, radiation therapy, life sciences, medical devices, biotechnology, oncology, manufacturing, PET scanner, electrical engineering, product engineering, algorithms engineer, new product development, and software engineering Type: | 2 | 2 | 1 | 240 |
 | Inspirna, Inc. Converting cancer to a manageable, chronic condition Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of high unmet need. Inspirna’s lead drug candidate, ompenaclid (RGX-202), is an orally-administered small molecule that targets the CKB/SLC6A8 pathway, which when activated enables the generation of ATP in response to tumor hypoxia. Ompenaclid is currently being tested in multiple mid-stage clinical trials in patients with advanced or metastatic RAS mutant colorectal cancer. Inspirna’s second clinical stage drug candidate, abequolixron (RGX-104), is an oral small molecule activator of LXR/APOE … Type: | 2 | 2 | 0 | 33 |
 | Artios Taking control of the DNA Damage Response (DDR) Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) and repair pathways that are leveraged by cancer cells to promote their survival. Our specialized DcoDeR platform integrates Artios’ leadership capabilities, expertise and experience in DNA damage biology and drug discovery to systematically discover and develop medicines targeting the totality of the DDR. We have built an extensive DDR focused pipeline designed to address areas of high unmet needs across solid tumour indications including our ATR inhibitor, ART0380, and our Polθ inhibitor ART6043, as monotherapy and combination treatments. … Type: | 7 | 3 | 0 | 113 |
 | ProQR Therapeutics Advancing our proprietary AxiomerTM RNA-editing platform technology Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary AxiomerTM RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/ RNA therapeutics, Drug development, Rare Diseases, Genetic Diseases, Orphan drugs, Pharmaceuticals, and RNA editing Type: | 3 | 3 | 1 | 163 |
 | May Health We are bringing a modern approach to the treatment of PCOS with our investigational Ovarian Rebalancing Treatment. May Health, formerly AblaCare, is developing a modern approach to PCOS. Type: | 1 | 1 | 1 | 16 |
 | Les Echos [Automatic translation follows] Find on LesEchos.fr all the economic and financial news in France and around the world, discover exclusive analyses, special reports, decryptions, chronicles and large formats. http://www.lesechos.fr/ Type: | 379 | 245 | 148 | 700 |
 | Palais de Tokyo [Automatic translation follows] Contemporary art center, Paris 📍 🔛 Mohamed Bourouissa, Dislocations, Touch the insane, Past disquiet With its 22,000 m2, the Palais de Tokyo stands out through its energy as one of the largest contemporary art centers in Europe. It encourages contemporary creation with an eclectic and inventive program around emerging and established artists from all backgrounds. contemporary art, exhibitions, performances, and concerts Type: | 13 | 7 | 7 | 163 |
 | Rothschild & Co We offer a distinct perspective that makes a meaningful difference to our clients' business and wealth. Rothschild & Co is one of the world's largest independent financial advisory groups. We offer a distinct perspective that makes a meaningful difference to our clients’ business and wealth. With a team of 4,200 talented financial services specialists on the ground in more than 40 countries across the world, we provide independent advice on M&A, strategy and financing, as well as investment and wealth management solutions to large institutions, families, individuals and governments. As a family-controlled business that has been at the centre of … Type: | 27 | 19 | 7 | 5,455 |
 | BIOWEG Revolutionizing the Future of Bio-ingredients BIOWEG, founded in 2019 in Germany, is a purpose-driven organization powered by conscious ChemDesign. We match Bio-innovation to business problems. We explore and combine biotechnology, material science, and molecular simulation learning to create advanced sustainable bio-based high-performance ingredients. Our ingredients are 100% animal free, globally scalable, and sustainably produced without harsh chemicals. We work with results-oriented, forward-thinking companies, and consumer brands with global scale in the cosmetics, personal care, nutraceuticals, agricultural coatings, and food/beverage sectors who desire highly differentiated and sustainable science-based ingredient technologies. Material Science, Fermentation , Green Chemistry, Alternative Ingredients, Biobased Materials, Biodegradabe, … Type: | 22 | 3 | 2 | 20 |
 | M&M Conseil [Automatic translation follows] Public affairs - Institutional relations M&M Conseil has specialized in the organization of institutional events and public affairs consulting for more than 25 years. Close to French and European institutions, we organize key meetings between public, private and institutional stakeholders. Public Affairs Consulting, Institutional Communication, Events, and Public Relations Type: | 86 | 6 | 83 | 8 |
 | Phacilitate Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences Type: | 4 | 1 | 3 | 18 |
 | Harlay Avocats #tech#startups#corporate#IP/IT#social#employment#tax Harlay Avocats (anciennement Kahn & Associés) est un cabinet d’avocats indépendant qui occupe depuis plus de vingt ans une place privilégiée dans le domaine du conseil aux entreprises de croissance et aux investisseurs dans les secteurs des technologies, de l’Internet, de l’e-commerce, des télécommunications, des sciences de la vie et des énergies renouvelables. La très bonne connaissance de ces secteurs d’activité permet au Cabinet d’être régulièrement sélectionné par les acteurs clés de ces domaines pour les assister lors de leurs opérations en France et à l’international. Le Cabinet conseille également les entreprises d’industries plus traditionnelles : presse et media, … | 5 | 0 | 4 | 37 |
 | Cellomatics Biosciences Ltd Our expertise, Your discovery Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. Based at Colwick Quays Business Park, Nottingham UK, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies. Multiplex Immunoassay, Target and biomarker validation, In vitro functional assays, Molecular Biology, Receptor binding, Toxicity testing, Immuno-Oncology, Oncology, Immunology, Inflammation, and Respiratory Type: | 1 | 0 | 0 | 20 |
 | AudioTelligence Disruptive hearing technology start-up (CLOSED) Situational hearing loss is a huge and growing problem worldwide, affecting over 80% of people over 40. Often called ‘The Cocktail Party Problem’, this means that sufferers can hear speech clearly in quiet rooms, but in noisy situations they find it hard to follow conversations. AudioTelligence’s aisoTM technology can supercharge hearing enhancement on your device. AisoTM goes a step further than other solutions which simply reduce background noise, by isolating and extracting the speech or sound that the user wants to hear from surrounding noise and unwanted sounds. With aisoTM, users can effectively regain their … Type: | 17 | 0 | 15 | 7 |
 | SafeHeal Reshaping RecoveryTM Established in 2015 and based in France, SafeHealTM is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented by French surgeon Charam Khosrovani to eliminate the need for diverting ostomies in patients undergoing colectomy. medical device Type: | 2 | 1 | 0 | 18 |
 | Acteurs de La French Care [Automatic translation follows] The grouping of players who support and develop the health ecosystem in France! The grouping of players who support and develop the health ecosystem in France! Type: | 22 | 4 | 19 | 1 |
 | Abzena Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, … Type: | 6 | 0 | 0 | 446 |
 | BIOKET Bioeconomy Key Enabling Technologies platform Process & Technology innovations for biobased solutions to food, feed, chemicals, biomaterials and bioenergies Trois-Rivières (QC), Canada -- May 23th-25th, 2023 -- Biomass is a wonderful ressource to be transformed into chemicals, biobased materials, food and feed ingredients or energy. Still, adaptation and optimisation of transformation processes and technologies is a real challenge in order to valorise all biomass fraction in a circular approach. In the context of Industry 4.0, the circular economy and the need for an optimal valorization of renewable resources, BIOKET is the only European conference dedicated to bio-based technologies and processes. Innovative Processes, Biotechnology, Green Chemistry, … Type: | 28 | 9 | 22 | 2 |
 | Syncona Limited Building the next generation of healthcare companies Syncona, is a leading FTSE 250 healthcare company focused on creating, building and scaling a portfolio of global leaders in life science. Our vision is to build a sustainable, diverse portfolio of 20- 25 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which we are seeking to deliver strong risk-adjusted returns for shareholders. We take a long-term view, underpinned by a strategic capital base which enables us to maintain significant ownership positions in our companies and provides us with control and flexibility over the management of … Type: | 9 | 3 | 1 | 51 |
 | Kymab Ltd Kymab, a Sanofi company, based in Cambridge UK, is working to provide novel solutions in drug and vaccine development. Kymab, a Sanofi company, is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available. Kymab’s platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with … Type: | 1 | 1 | 0 | 49 |
 | Myricx Bio Developing a new class of ADCs based on NMT inhibition to treat cancer We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer. Type: | 2 | 1 | 1 | 12 |
 | Startup Insider [Automatic translation follows] The most important news, trends and investments from the German startup scene. With Startup Insider, a new industry portal is being created for the startup scene in Germany, Austria and Switzerland. Here you can find news from all regions and industries as well as an overview of the most important players and events in the German-speaking startup world. Startup Insider's mission is to support startups on their path to success. We help startups and grow-ups make contacts with investors and customers, find new employees or gain media visibility at events or online, in print or newsletters. Startups, … Type: | 29 | 4 | 26 | 34 |
 | Cyber Valley Europe’s largest AI research consortium Cyber Valley is Europe’s largest and leading research consortium in the field of artificial intelligence (AI) and modern robotics. Cyber Valley has a mission and a public mandate to advocate for entrepreneurship, research, development, application, and acceptance of technologies and methods in the field of intelligent systems. The company envisions a future where the full potential of intelligent systems is leveraged for the greater good of the world. The Cyber Valley Community connects partners from science, industry, and society, along with AI researchers and entrepreneurs. The Cyber Valley GmbH is funded by the state of … Type: | 9 | 1 | 6 | 20 |
 | Parkinson's UK We’ll find a cure. Together. Powered by people. Funded by you. Improving life for everyone affected by Parkinson’s. Your mum, colleague or friend. Anyone can get Parkinson’s, young or old. Every hour, two more people are diagnosed. Unlocking new treatments means delving into the causes of Parkinson’s. That’s why we fund the Parkinson's UK Brain Bank – the world's only brain bank dedicated to Parkinson's research. Over 10,000 people have donated their brains to help scientists around the world to unravel the mysteries of the condition and develop better treatments. The largest charitable funder of Parkinson’s research in Europe, we’re … Type: | 1 | 0 | 0 | 586 |
 | BioCentury Inc. The leading voice for decision makers throughout the global healthcare ecosystem. BioCentury gives biopharma executives, investors and institutions the power to make business-critical decisions through independent, deep-dive analysis; high-quality data; and industry-leading business intelligence, and global events. When you subscribe to BioCentury, our team of Ph.D.s, analysts and industry experts become an extension of your team, helping you answer critical questions, decipher strategic trends, objectively evaluate product and business strategies, and assess competitive, financial, and policy risks. We also help you to build your network by connecting you the who’s who in the industry. Watch the latest episodes of The … Type: | 10 | 4 | 8 | 77 |
 | Parc Científic de Barcelona [Automatic translation follows] Where Science becomes Business Located in the knowledge campus, the PCB provides you with basic ordinary services and a privileged environment for networking. More than 2,700 highly qualified researchers work at the PCB; join our community! | 5 | 2 | 3 | 107 |
 | Merck At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and … Type: | 15 | 14 | 0 | 67,800 |
 | Pyrowave Electrifying progress. We are leading the revolution in #sustainable #greenchemistry by offering a modular microwave based technology that can #unzip waste plastics back to their root chemical form. Styrene, Polyolefin wax, Lubricants, Microwave, Plastics, #CircularEconomy, #LowCarbonCement , CleanTechnology, #Nanorecycling, GreenSolutions, and #WasteReduction Type: | 5 | 1 | 4 | 15 |
 | Intermediate Capital Group (ICG) Global alternative asset manager, creating sustainable value by partnering with ambitious businesses. We are a global alternative asset manager with a track record of over 30 years. We are driven by purpose and sustainable results. We deliver outstanding investment performance to our clients, provide wide‐ranging capital solutions for corporates and owners of real assets, and create value for stakeholders, shareholders and communities. Private Markets, Private Capital, Alternative Asset Management, Private Credit, Private Debt, Secondaries, Structured Products, Real Assets, Infrastructure, Real Estate, and Life Sciences Type: | 6 | 1 | 2 | 739 |
 | Apollo Global Management, Inc. Apollo is a high-growth alternative asset manager. Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade to private equity with a focus on three investing strategies: yield, hybrid, and equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a … Type: | 16 | 3 | 6 | 3,874 |
 | STAT Reporting from the frontiers of health and medicine. Reporting from the frontiers of health and medicine We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all. Get access to exclusive content: http://www.statnews.com. Follow us on Twitter @statnews and on Facebook at facebook.com/statnews news, science news, medicine, health, biotech, pharma, health tech, and covid Type: | 22 | 7 | 12 | 317 |
 | Northzone Northzone is a venture capital fund shaped by lives as entrepreneurs and investors. Founded in 1996. Northzone is a technology investment partnership. With two decades of experience, we have been chosen by some of the best entrepreneurs as their long-term partner for growth. With offices across the Nordics, London and in New York, we work around the clock to connect our companies with customers, business partners and key talent on a truly international scale. As former entrepreneurs ourselves, we have been sat on both sides of the table, and place the relationships with our Founders at the core of our … Type: | 31 | 15 | 21 | 54 |
 | Evaluate Ltd Evaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action: Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential. EvaluatePharma - the trusted global view of the … Type: | 7 | 1 | 5 | 200 |
 | VERTEXA Digital Therapeutics [Automatic translation follows] VERTEXA is an immersive therapeutic game, in virtual reality. Let’s digitalize health! VERTEXA digital therapy (Virtual Reality Therapy Exposition in Anorexia) aims to use virtual reality as a support tool in the form of a gamified and immersive psychoeducational course in patients suffering from eating disorders (anorexia, bulimia). The use of digital tools and new technologies now allow an innovative, personalized, motivating and accessible approach regardless of where our patients are cared for. The VERTEXA tool is intended to be autonomous: the patient is involved in his or her care. He will be immersed in a soothing … Type: | 21 | 2 | 21 | 4 |
 | AFI Ventures Europe’s Day-One Impact Launchpad At AFI Ventures, we are committed to backing the most promising seed & pre-seed impact entrepreneurs. From climate action to healthy living, we partner with every visionary that shares the ambition of deep, at-scale impact. We are investing up to 500k€ in 1 to 2 companies every month. AFI Ventures is the seed fund of Alliance for Impact, Europe's day one impact launchpad. impactinvesting, capitalrisque, VC, impact, startup, fonds, seed, financement, entrepreneurship, and socialbusiness Type: | 15 | 11 | 4 | 5 |
 | Owkin We use AI to find the right treatment for every patient. Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions shared by biopharma and academic researchers. By closing the translational gap between complex biology and new treatments, we bring new diagnostics and drugs to patients sooner. We use AI to identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools. Using federated learning, a pioneering collaborative AI framework, Owkin enables partners to unlock valuable insights from … Type: | 32 | 11 | 22 | 438 |
 | Ulysse Communication [Automatic translation follows] Who better than former journalists to make your voice heard? Ulysse Communication, at the crossroads of press and communication. Specializing in press relations and financial communications, Ulysse Communication was created by former economic and financial journalists who themselves surrounded themselves with former journalists. The agency and the team are strongly marked by this DNA which translates into an intimate knowledge of the media, an ability to develop tailor-made messages and a good understanding of the economic and business world. Press relations, Financial communication, Finance, Listed company, IPO, Financial operations, Public relations, Corporate communication, Asset management, Real estate, … Type: | 41 | 0 | 40 | 14 |
 | Silicon Valley Bank Silicon Valley Bank (SVB), a division of First Citizens Bank, is the bank of the world’s most innovative companies and investors. SVB provides commercial and private banking to individuals and companies in the technology, life science and healthcare, private equity, venture capital and premium wine industries. SVB operates in centers of innovation throughout the United States, serving the unique needs of its dynamic clients with deep sector expertise, insights and connections. SVB's parent company, First Citizens Bancshares, Inc. (NASDAQ: FCNCA) is a top 20 U.S. financial institution with more than $200 billion in assets. First Citizens Bank, Member FDIC. Learn … Type: | 113 | 40 | 32 | 5,344 |
 | baby vc Come for a VC bootcamp, stay for the community. First bootcamp for those who aspire to join the venture capital community. A unique program during which a group of aspiring VCs meet those who make venture capital. They reveal to us behind the scenes, the secrets and the future of their profession. Have a look at our job board juste here: [https://airtable.com/shrePuJCHfJbTq17m/tblsaFTVJnUA2JWuY] Are you a venture capital fund or startup looking for a stellar addition to your team? Then add your job offer via this form [https://airtable.com/shrYcgd6zU6VAKlRL] to get access to our fellows and our community 🤓 venture capital, bootcamp, … Type: | 61 | 2 | 59 | 200 |
 | Algorithmiq We develop advanced quantum algorithms to solve complex problems in life sciences Algorithmiq is a company developing advanced algorithms to solve complex problems in life sciences. Our mission is to revolutionise life sciences by exploiting the potential of quantum computing to solve currently inaccessible problems. We combine our expertise in quantum information, complex systems, and computational physics to develop algorithms that run on near-term quantum devices to discover new drugs and develop new materials Quantum physics, Complex networks, Quantum computing, Quantum simulations, Quantum chemistry, Quantum software, and Computational physics Type: | 7 | 0 | 7 | 37 |
 | Panakes Partners Life Sciences dedicated VC firm Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world, in two funds. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250 million under management. Panakes brings strong entrepreneurial and financial expertise to portfolio companies well beyond just capital, relying on a wide network of clinicians and industry experts. We have established relationships with selected industrial partners to assist our … Type: | 12 | 2 | 7 | 18 |
 | Wellcome Sanger Institute The Wellcome Sanger Institute is a world leading genomics research centre. The Wellcome Sanger Institute is a world leader in genomics research. We generate and analyse data at a scale not easily possible elsewhere. We apply and explore genomic technologies to advance the understanding of biology and improve health. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve … Type: | 4 | 3 | 1 | 1,394 |
 | TECHNION FRANCE [Automatic translation follows] French representation of the Technion, Israel Institute Of Technology The Technion France's mission is to promote the Technion, Israel Institute of Technology, in scientific, industrial and economic circles and to publicize the Technion's achievements and projects in the fields of scientific and technological research. In addition, it intends to encourage the establishment of close relationships between these environments and all the scientists, teachers and students of the Technion, for the development of cooperation on projects of common interest. It also aims to increase the number of events and conferences in France by inviting professors specializing in Israel. … Type: | 43 | 13 | 28 | 11 |
 | centdegrés Creative Activists Since 1988 We believe in bold creativity. For thirty years, we’ve focused all our energies on helping our clients win their battles, improve their impact, and challenge the status quo. Through design. We hunt down the best conditions for your projects in order to create unique personalised design and make a new kind of impact. Anything that will only achieve a partial result is a waste of time. We live by the certainty that there is no such thing as “hype”, freedom and creativity are crucial aspects of our approach. We have continuously created exceptional experiences, brands, products … | 2 | 2 | 2 | 62 |
 | United Ventures We support visionary entrepreneurs to reinvent industries through technology. At United Ventures we look for daring entrepreneurs willing to develop innovative products and technologies, who acknowledge the challenges and risks of our times and still crave to come out on top in business. As entrepreneurs ourselves, our mission is to spot winners and drive them to achieve success and worldwide recognition through our mentorship, financial and business development support. With a long-standing track record of both start-up and scale-up technological companies, we can boast the industry expertise, mentorship and business networking that it takes to create a success story. Thanks … Type: | 16 | 2 | 10 | 48 |
 | Triple Ring Technologies A trusted partner in bringing technology to life. Triple Ring Technologies is a co-development company headquartered in Silicon Valley, with offices in Boston, Toronto, and Copenhagen. We partner with clients in medtech, life sciences, and sustainability & the environment to create new technologies, launch innovative projects, and start new ventures. Our capabilities span early R&D, product development, manufacturing, regulatory approval, market access, strategic investment, and incubation. For more information, please visit www.tripleringtech.com. For inquiries, please email info@tripleringtech.com. Advanced Research & Development - applied to commercial problems, Innovation Programs, Medical Device Design, Prototyping, Modeling, Validation, Product Development / Design, Grant Funded … Type: | 3 | 0 | 3 | 102 |
 | BIOTECanada Solving for today. Building for tomorrow. BIOTECanada serves as the national voice for Canada’s biotechnology sector. BIOTECanada is the national industry-funded association with over 250 member companies representing the broad spectrum of biotech constituents including emerging and established firms in the health, industrial, and agricultural sectors, as well as academic and research institutions and other related organizations. Through our national network of partner organisations, we inspire our domestic and international community to recognize the value of biotechnology and to provide solutions to the challenges faced by biotech firms today. Visit us at www.biotech.ca, and discover Canada's Biotechnology and Lifesciences Community … | 6 | 1 | 5 | 25 |
 | Kickston [Automatic translation follows] Fundraising I M&A Kickston is a merchant bank that supports entrepreneurs in their fundraising and M&A operations. Industries: Consumer & B2B Tech • Fundraising: 2 to 10M€ • Transfer: Operations up to €15M Are you interested in our approach? Contact us! contact@kickston.co Type: | 27 | 1 | 27 | 9 |
 | Shockwave Medical Making waves for underserved patients with cardiovascular disease via novel technologies. ⚡🌊 Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with … Type: | 2 | 2 | 1 | 1,123 |
 | StartupItalia Scarica il paper investimenti 2023👉 https://bit.ly/PaperSIOS23Winter We are now ready to take the next step to create a launchpad with significant impact on the creation of new startups in Italy. Platform with data from startups, innovative companies, investors and skilled people. Educational platform to support mindset building and training for a future generation of entrepreneurs with clear vertical specializations. Services and support for a new generation of startups with appropriate growth models Flexible space to bring together the ecosystem and support flexible expansions for startups and Corporates/SMEs. "The largest Italian community targeting founders, investors, developers and students " Source: IBM … Tags: H2020 Type: | 54 | 16 | 35 | 97 |
 | Citeline Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health care professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory-related decisions and create real-world opportunities for growth. Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. Type: | 12 | 10 | 2 | 420 |
 | OBN (UK) Ltd The membership organisation supporting & bringing together UK’s life sciences companies, corporate partners & investors OBN is the membership organisation supporting and bringing together the UK's emerging life science companies, corporate partners and investors. Our 450+ member companies are located across the Golden Triangle and beyond, and benefit from our networking, partnering, purchasing, advising, and advocacy activities. OBN organises BioTrinity - Europe's Leading Investment and Biopartnering Conference, find out more at www.biotrinity.com. Networking Events, Partnering (BioTrinity), Advising: Cluster Analysis and Business Development, Group Purchasing Consortium, Advocacy, Conferences, BioTech, and Life Sciences Type: | 8 | 4 | 4 | 29 |
 | Andreessen Horowitz Software is eating the world Founded in 2009 by Marc Andreessen and Ben Horowitz, Andreessen Horowitz (known as "a16z") is a venture capital firm that backs bold entrepreneurs building the future through technology. We are stage agnostic: We invest in seed to late-stage technology companies, across the consumer, enterprise, bio/healthcare, crypto, fintech and games spaces. a16z is defined by respect for the entrepreneur and the entrepreneurial company building process; we know what it’s like to be in the founder’s shoes. The firm is led by general partners, many of whom are former founders/operators, CEOs, or CTOs of successful technology companies, … Type: | 69 | 27 | 20 | 659 |
 | 4BIO Capital London-based venture fund investing in advanced therapies 4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious … Type: | 6 | 2 | 4 | 17 |
 | McDermott Will & Emery A global law firm helping propel today’s most respected, dynamic and important organizations. McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With 20+ locations globally, our team works seamlessly across practices, industries and geographies to deliver highly effective—and often unexpected—solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve. Attorney Advertising. Prior results do not guarantee a similar outcome. Type: | 10 | 4 | 6 | 3,144 |
 | Dechert LLP Dechert is a global law firm that advises asset managers, financial institutions and corporations on issues critical to managing their business and their capital – from high-stakes litigation to complex transactions and regulatory matters. We answer questions that seem unsolvable, develop deal structures that are new to the market and protect clients’ rights in extreme situations. Our 1,000+ lawyers across 21 offices globally focus on the financial services, private equity, private credit, real estate, life sciences and technology sectors. © 2024 Dechert LLP. All rights reserved. This information should not be considered as legal opinions on specific facts or as … Type: | 10 | 6 | 5 | 2,229 |
 | Medicines Discovery Catapult Reshaping drug discovery for patient benefit. Independent, not-for-profit national innovation centre for drug discovery. We collaborate with UK medicines discovery and diagnostics organisations, giving them access to industry-leading expertise, cutting-edge technology, and high-quality data. We accelerate their progress, precision drugs get to clinical trials more rapidly, and patients get life-improving medicines earlier than they otherwise would have. biotechnology, pharma, medicines discovery, biotech, informatics, pharmaceuticals, drug discovery, tissue samples, discovery science and technology, virtual research and development, mass spectrometry, complex cell models, clinical data, biomarkers, tissue imaging, drug delivery, target engagement, target validation, omics, and drug research Type: | 9 | 2 | 6 | 194 |
 | Labiotech.eu The leading digital media covering global biotech innovation Labiotech.eu is the leading digital media covering the global biotech industry. Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Join them now and enjoy reading our stories! "We are building the Next Generation of Digital Media for Biotech" Philip & Joachim, Founders of Labiotech.eu Biotechnology, Life science, News, and Media Type: | 21 | 3 | 18 | 9 |
 | SV Health Investors Investing in tomorrow's healthcare breakthroughs SV Health Investors is a specialist healthcare fund manager, investing across stages, geographic regions, and sectors, with expertise spanning biotechnology, dementia, healthcare growth, healthcare technology. Alongside our core funds, SV manages the Dementia Discovery Fund, focused on discovering and developing novel therapeutics for dementia. Venture Capital, Biotechnology, Medical Devices, Healthcare services, Private Equity, and Dementia Type: | 9 | 1 | 9 | 101 |
 | RELEVATION The Global digital fundraising Summit for PropTech startups Relevation.org is the global digital investment summit in UrbanTech; a 2 days event of match-making between investors (BA, family offices, VC, CVC...) and startups across all the stages of maturity in fund raising process Type: | 21 | 3 | 20 | 3 |
Public